These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 10952951)
1. Effect of cholesterol-lowering therapy on coronary endothelial vasomotor function in patients with coronary artery disease. Vita JA; Yeung AC; Winniford M; Hodgson JM; Treasure CB; Klein JL; Werns S; Kern M; Plotkin D; Shih WJ; Mitchel Y; Ganz P Circulation; 2000 Aug; 102(8):846-51. PubMed ID: 10952951 [TBL] [Abstract][Full Text] [Related]
3. Cholesterol lowering with pravastatin improves resistance artery endothelial function: report of six subjects with normal coronary arteriograms. Houghton JL; Pearson TA; Reed RG; Torosoff MT; Henches NL; Kuhner PA; Philbin EF Chest; 2000 Sep; 118(3):756-60. PubMed ID: 10988199 [TBL] [Abstract][Full Text] [Related]
4. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Collins R; Armitage J; Parish S; Sleight P; Peto R; Lancet; 2004 Mar; 363(9411):757-67. PubMed ID: 15016485 [TBL] [Abstract][Full Text] [Related]
5. Heterogeneous vasomotor responses of coronary conduit and resistance vessels in hypertension. Houghton JL; Davison CA; Kuhner PA; Torossov MT; Strogatz DS; Carr AA J Am Coll Cardiol; 1998 Feb; 31(2):374-82. PubMed ID: 9462582 [TBL] [Abstract][Full Text] [Related]
6. The effect of simvastatin on progression of coronary artery disease. The Multicenter coronary Intervention Study (CIS). Bestehorn HP; Rensing UF; Roskamm H; Betz P; Benesch L; Schemeitat K; Blümchen G; Claus J; Mathes P; Kappenberger L; Wieland H; Neiss A Eur Heart J; 1997 Feb; 18(2):226-34. PubMed ID: 9043838 [TBL] [Abstract][Full Text] [Related]
7. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. O'Driscoll G; Green D; Taylor RR Circulation; 1997 Mar; 95(5):1126-31. PubMed ID: 9054840 [TBL] [Abstract][Full Text] [Related]
8. Endothelial Effect of Statin Therapy at a High Dose Versus Low Dose Associated with Ezetimibe. Garcia MM; Varela CG; Silva PF; Lima PR; Góes PM; Rodrigues MG; Silva Mde L; Ladeia AM; Guimarães AC; Correia LC Arq Bras Cardiol; 2016 Apr; 106(4):279-88. PubMed ID: 27142792 [TBL] [Abstract][Full Text] [Related]
9. Protective effects of simvastatin on coronary artery function in swine with acute infection. Liuba P; Pesonen E; Forslid A; Paakkari I; Kornerup-Hansen A; Kovanen P; Pentikäinen M; Persson K; Østergård G Atherosclerosis; 2006 Jun; 186(2):331-6. PubMed ID: 16223501 [TBL] [Abstract][Full Text] [Related]
10. Coronary endothelial dysfunction is not rapidly reversible with ascorbic acid. Widlansky ME; Biegelsen ES; Hamburg NM; Duffy SJ; Keaney JF; Vita JA Free Radic Biol Med; 2004 Jan; 36(1):123-30. PubMed ID: 14732296 [TBL] [Abstract][Full Text] [Related]
11. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Leung WH; Lau CP; Wong CK Lancet; 1993 Jun; 341(8859):1496-500. PubMed ID: 8099379 [TBL] [Abstract][Full Text] [Related]
12. [The effects after withdrawal of simvastatin on brachial artery endothelial function in patient with coronary heart disease or risk factors]. Chen H; Ren JY; Wu B; Liu X; Wang RJ; Li LJ; Luo Y Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):531-5. PubMed ID: 17711713 [TBL] [Abstract][Full Text] [Related]
13. Ezetimibe in Combination With Statins Ameliorates Endothelial Dysfunction in Coronary Arteries After Stenting: The CuVIC Trial (Effect of Cholesterol Absorption Inhibitor Usage on Target Vessel Dysfunction After Coronary Stenting), a Multicenter Randomized Controlled Trial. Takase S; Matoba T; Nakashiro S; Mukai Y; Inoue S; Oi K; Higo T; Katsuki S; Takemoto M; Suematsu N; Eshima K; Miyata K; Yamamoto M; Usui M; Sadamatsu K; Satoh S; Kadokami T; Hironaga K; Ichi I; Todaka K; Kishimoto J; Egashira K; Sunagawa K Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):350-358. PubMed ID: 27932353 [TBL] [Abstract][Full Text] [Related]
14. Early effects of statin therapy on endothelial function and microvascular reactivity in patients with coronary artery disease. Ling MC; Ruddy TD; deKemp RA; Ukkonen H; Duchesne L; Higginson L; Williams KA; McPherson R; Beanlands R Am Heart J; 2005 Jun; 149(6):1137. PubMed ID: 15976803 [TBL] [Abstract][Full Text] [Related]
15. Ezetimibe/simvastatin 10/20 mg versus simvastatin 40 mg in coronary heart disease patients. Averna M; Zaninelli A; Le Grazie C; Gensini GF J Clin Lipidol; 2010; 4(4):272-8. PubMed ID: 21122660 [TBL] [Abstract][Full Text] [Related]
16. Cholesterol levels after 3 days of high-dose simvastatin in patients at moderate to high risk for coronary events. Michelena HI; Osorio LA; Citkowitz E Int J Cardiol; 2005 May; 101(1):111-4. PubMed ID: 15860392 [TBL] [Abstract][Full Text] [Related]
17. Tetrahydrobiopterin improves endothelial dysfunction in coronary microcirculation in patients without epicardial coronary artery disease. Setoguchi S; Mohri M; Shimokawa H; Takeshita A J Am Coll Cardiol; 2001 Aug; 38(2):493-8. PubMed ID: 11499743 [TBL] [Abstract][Full Text] [Related]
18. Influence of smoking status on angiotensin-converting enzyme inhibition-related improvement in coronary endothelial function. TREND Investigators. Trial on Reversing Endothelial Dysfunction. Schlaifer JD; Mancini GB; O'Neill BJ; Pitt B; Haber HE; Pepine CJ Cardiovasc Drugs Ther; 1999 May; 13(3):201-9. PubMed ID: 10439882 [TBL] [Abstract][Full Text] [Related]
19. A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study. Lüscher TF; Pieper M; Tendera M; Vrolix M; Rutsch W; van den Branden F; Gil R; Bischoff KO; Haude M; Fischer D; Meinertz T; Münzel T Eur Heart J; 2009 Jul; 30(13):1590-7. PubMed ID: 19474053 [TBL] [Abstract][Full Text] [Related]
20. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Pyŏrälä K; Pedersen TR; Kjekshus J; Faergeman O; Olsson AG; Thorgeirsson G Diabetes Care; 1997 Apr; 20(4):614-20. PubMed ID: 9096989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]